Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Indonesian Health Journal
Luh Putu Serly Ekayanti, Ni
Unknown Affiliation
Dentistry Health Professions Medicine & Pharmacology Nursing Public Health Veterinary

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Comparative Effectiveness Of Ramipril Versus Losartan In Adults With Primary Hypertension: A Scoping Review Ngurah Pradnya Wibawa, Putu; Putu Lia Juliantini, Ni; Luh Putu Serly Ekayanti, Ni
Indonesian Health Journal Vol. 5 No. 1 (2026): Indonesian Health Journal
Publisher : Riviera Publishing

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58344/ihj.v5i1.831

Abstract

Hypertension remains one of the leading global risk factors for cardiovascular morbidity and mortality. Despite the availability of multiple antihypertensive drug classes, achieving optimal blood pressure control continues to be a major clinical challenge worldwide. This research aims to compare the efficacy of Ramipril and Losartan in the management of Primary Hypertension. This scoping review analyzed articles published between January 2006 and January 2026 from PubMed, ScienceDirect, OpenAlex, and DOAJ. Inclusion criteria included English-language observational studies addressing the efficacy of both antihypertensives. Four articles were selected after a rigorous screening process. Ramipril was more effective in reducing SBP and DBP, whereas Losartan was superior for EF and LV remodeling. Ramipril also increased GSH and total antioxidant status, while Losartan was more effective for metabolic and vascular remodeling biomarkers. Ramipril is commonly associated with adverse effects such as cough, whereas dizziness is more frequently reported with Losartan. Losartan has been shown to be more effective in hypertensive patients with left ventricular hypertrophy (LVH) and may also contribute to improvements in insulin resistance. Further head-to-head comparison studies are needed to guide optimal therapy.
Co-Authors Ngurah Pradnya Wibawa, Putu Putu Lia Juliantini, Ni